Thursday May 17,2012

HQH Pricing Info
AS OF: 5/16/2012
HQH NAV: 18.04
HQH STOCK: 16.8
PREMIUM/DISCOUNT: -6.87%
*See Legal Disclaimer

HQL Pricing Info
AS OF: 5/16/2012
HQL NAV: 14.88
HQL STOCK: 14.46
PREMIUM/DISCOUNT: -2.82%
*See Legal Disclaimer
Hambrecht & Quist Capital Management, LLC ("HQCM"), a registered investment adviser based in Boston, Massachusetts, is currently the investment adviser for two closed-end equity funds, H&Q Healthcare Investors and H&Q Life Sciences Investors. The Funds invest in growth equities, both public and private, in the healthcare and life sciences industries.



Distribution Reinstatement Letter to Shareholders

Announcement of Share Repurchase Programs


HQH and HQL


Annual Meeting Invitation
HQH Proxy
HQL Proxy


HQH 2011 Tax Information
HQL 2011 Tax Information

Funds


MORE

H&Q Healthcare Investors ("HQH") is a broadly diversified closed-end healthcare fund traded on the New York Stock Exchange under the ticker HQH. HQH primarily invests in biotechnology, medical devices, and pharmaceuticals. The Fund's objective is to provide long-term capital appreciation through investments in companies in the health technology industries believed to have significant potential for above-average long-term growth. Selection will emphasize the smaller, emerging companies with a maximum of 40% of the Fund's assets in restricted securities of both public and private companies. Management believes this provides a unique opportunity not usually available to mutual fund investors.



MORE

H&Q Life Sciences Investors ("HQL") is a broadly diversified closed-end healthcare fund traded on the New York Stock Exchange under the ticker HQL. HQL primarily invests in biotechnology, medical devices, and pharmaceuticals. The Fund's objective is to provide long-term capital appreciation through investments in companies in the health technology industries believed to have significant potential for above-average long-term growth. Selection will emphasize the smaller, emerging companies with a maximum of 40% of the Fund's assets in restricted securities of both public and private companies. Management believes this provides a unique opportunity not usually available to mutual fund investors.

Recent Press Releases